Skip to main content
. 2024 Jan 20;15:645. doi: 10.1038/s41467-024-44874-3

Table 6.

Pharmacokinetic parameters of compound 11c

Tissue Cmax (ng equiv./g) Tmax (h) T1/2 (h) AUC0-t (ng equiv./g) AUCinf (ng equiv./g) Tissue: plasma**
Plasma 225 0.5 NC 783 NC 1.00
Whole Blood 158 0.5 NC 589 NC 0.75
Adrenal gland 1510 6 NC 7210 NC 9.21
Brain BQL NC NC NR NC NA
Heart 369 6 NC 1800 NC 2.30
Kidney 1840 6 NC 7860 NC 10.0
Large Intestine 9800 6 NC 127000 NC 162
Liver 2920 6 NC 15400 NC 19.7
Lung 941 6 NC 4290 NC 5.48
Pancreas 4330 6 NC 15400 NC 19.7
Small Intestine 45000 0.25 NC 16600 NC 21.2
Spleen 2290 6 NC 9520 NC 12.2
Stomach 3240 0.25 NC 5130 NC 6.55

Equivalents in Plasma and Tissue of Male Sprague Dawley Rats following an Oral Dose of [14C]-11c at 5 mg/kg. (NC= Not calculated due to insufficient terminal elimination phase, NA Not applicable, NR Not reportable due to <3 consecutive quantifiable concentrations, BQL Below the lower limit of quantitation 148 ng equiv./g, **Tissue: plasma ratio based on AUC0-t).